Cell cycle effects of gemcitabine
2001-01-01 Cappella, P; Tomasoni, D; Faretta, M; Lupi, M; Montalenti, F; Viale, F; Banzato, F; D'Incalci, M; Ubezio, P
Clinical pharmacokinetics of the new oral camptothecin gimatecan: The inter-patient variability is related to alpha(1)-acid glycoprotein plasma levels
2010-01-01 Frapolli, R; Zucchetti, M; Sessa, C; Marsoni, S; Vigano, L; Locatelli, A; Rulli, E; Compagnoni, A; Bello, E; Pisano, C; Carminati, P; D'Incalci, M
Not only tumor but also therapy heterogeneity
2018-01-01 Garattini, S; Nerini, If; D'Incalci, M
Effectiveness of the antineoplastic drug Ecteinascidin 743 against sensitive and multidrug resistant sarcoma cells: A preclinical evaluation
2001-01-01 Scotlandi, K; Perdichizzi, S; Manara, Mc; Serra, M; Faircloth, Gt; Picci, P; D'Incalci, M
In human tumor xenografts the resistance to ET-743 or to cisplatin can be overcome by giving the two drugs in combination
2002-01-01 D'Incalci, M; Colombo, T; Giavazzi, G; Nicoletti, I; Erba, E; Ubezio, P; Meco, D; Riccardi, R; Jimeno, J; Faircloth, G
Novel camptothecin ST1968 is very active in pediatric tumors xenografts models with negligible toxicity as compared to Irinotecan
2007-01-01 Meco, D; Di Francesco, Am; Servidei, T; Torellal, Ar; Cusano, G; D'Incalci, M; Pisano, C; Riccardi, R
A biodistribution study of PEGylated PCL-based nanoparticles in C57BL/6 mice bearing B16/F10 melanoma
2014-01-01 Lupi, M; Colombo, C; Frapolli, R; Ferrari, R; Sitia, L; Dragoni, L; Bello, E; Licandro, Sa; Falcetta, F; Ubezio, P; Bigini, P; Salmona, M; D'Incalci, M; Morbidelli, M; Moscatelli, D
CHANGES IN THE SYNTHESIS OF HISTONE H1-DEGREES AND H-1 IN RAT FRTL-5 THYROID-CELLS EXPOSED TO THYROTROPIN
1989-01-01 Mannironi, C; Erba, E; Corda, D; Gianellini, L; D'Incalci, M
The novel lipophilic camptothecin analogue gimatecan is very active in vitro in human neuroblastoma: A comparative study with SN38 and topotecan
2005-01-01 Di Francesco, Am; Riccardi, As; Barone, G; Rutella, S; Meco, D; Frapolli, R; Zucchetti, M; D'Incalci, M; Pisano, C; Carminati, P; Riccardi, R
IFN-beta partially counteracts inhibition of natural killer activity induced by some antitumor agents
1998-01-01 Allavena, P; Giardina, G; Sen, S; Colella, G; Broggini, M; D'Incalci, M
Novel Models of Myxoid Liposarcoma Xenografts Mimicking the Biological and Pharmacologic Features of Human Tumors
2010-01-01 Frapolli, R; Tamborini, E; Virdis, E; Bello, E; Tarantino, E; Marchini, S; Grosso, F; Sanfilippo, R; Gronchi, A; Tercero, Jc; Peloso, G; Casali, P; Pilotti, S; D'Incalci, M
Idarubicin and melphalan as myeloablative regimen after sequential high dose chemotherapy for lymphomas: Preliminary results of a phase I-II study with pharmacokinetical guided peripheral blood progenitor cell reinfusion
1997-01-01 Peccatori, F; Cocorocchio, E; Munzone, E; Corsini, C; Zucchetti, M; Ferrucci, Pf; Cinieri, S; D'Incalci, M; Martinelli, G
Phase II trial of salvage therapy with trabectedin in metastatic pancreatic adenocarcinoma
2016-01-01 Belli, C; Piemonti, L; D'Incalci, M; Zucchetti, M; Porcu, L; Cappio, S; Doglioni, C; Allavena, P; Ceraulo, D; Maggiora, P; Dugnani, E; Cangi, Mg; Garassini, G; Reni, M
Paclitaxel induces significant changes in epidoxorubicin distribution in mice
1996-01-01 Colombo, T; Paz, Og; Zucchetti, M; Maneo, M; Sessa, C; Goldhirsch, A; D'Incalci, M
Development of distamycin-related DNA binding anticancer drugs
2001-01-01 Marchini, S; Broggini, M; Sessa, C; D'Incalci, M
Increased sensitivity to platinum drugs of cancer cells with acquired resistance to trabectedin
2015-01-01 Colmegna, B; Uboldi, S; Frapolli, R; Licandro, Sa; Panini, N; Galmarini, Cm; Badri, N; Spanswick, Vj; Bingham, Jp; Kiakos, K; Erba, E; Hartley, Ja; D'Incalci, M
Effects of a novel DNA-damaging agent on the budding yeast Saccharomyces cerevisiae cell cycle
1996-01-01 Popolo, L; Vigano, F; Erba, E; Mongelli, N; D'Incalci, M
Use of cancer chemopreventive phytochemicals as antineoplastic agents
2005-01-01 D'Incalci, M; Steward, Wp; Gescher, Aj
alpha 1 acid glycoprotein binds to imatinib (ST1571) and substantially alters its pharmacokinetics in chronic myeloid leukemia patients
2003-01-01 Gambacorti-Passerini, C; Zucchetti, M; Russo, D; Frapolli, R; Verga, M; Bungaro, S; Tornaghi, L; Rossi, F; Pioltelli, P; Pogliani, E; Alberti, D; Corneo, G; D'Incalci, M
microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial-mesenchymal transition
2014-01-01 Parikh, A; Lee, C; Joseph, P; Marchini, S; Baccarini, A; Kolev, V; Romualdi, C; Fruscio, R; Shah, H; Wang, F; Mullokandov, G; Fishman, D; D'Incalci, M; Rahaman, J; Kalir, T; Redline, Rw; Brown, Bd; Narla, G; Difeo, A
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Cell cycle effects of gemcitabine | 1-gen-2001 | Cappella, P; Tomasoni, D; Faretta, M; Lupi, M; Montalenti, F; Viale, F; Banzato, F; D'Incalci, M; Ubezio, P | |
| Clinical pharmacokinetics of the new oral camptothecin gimatecan: The inter-patient variability is related to alpha(1)-acid glycoprotein plasma levels | 1-gen-2010 | Frapolli, R; Zucchetti, M; Sessa, C; Marsoni, S; Vigano, L; Locatelli, A; Rulli, E; Compagnoni, A; Bello, E; Pisano, C; Carminati, P; D'Incalci, M | |
| Not only tumor but also therapy heterogeneity | 1-gen-2018 | Garattini, S; Nerini, If; D'Incalci, M | |
| Effectiveness of the antineoplastic drug Ecteinascidin 743 against sensitive and multidrug resistant sarcoma cells: A preclinical evaluation | 1-gen-2001 | Scotlandi, K; Perdichizzi, S; Manara, Mc; Serra, M; Faircloth, Gt; Picci, P; D'Incalci, M | |
| In human tumor xenografts the resistance to ET-743 or to cisplatin can be overcome by giving the two drugs in combination | 1-gen-2002 | D'Incalci, M; Colombo, T; Giavazzi, G; Nicoletti, I; Erba, E; Ubezio, P; Meco, D; Riccardi, R; Jimeno, J; Faircloth, G | |
| Novel camptothecin ST1968 is very active in pediatric tumors xenografts models with negligible toxicity as compared to Irinotecan | 1-gen-2007 | Meco, D; Di Francesco, Am; Servidei, T; Torellal, Ar; Cusano, G; D'Incalci, M; Pisano, C; Riccardi, R | |
| A biodistribution study of PEGylated PCL-based nanoparticles in C57BL/6 mice bearing B16/F10 melanoma | 1-gen-2014 | Lupi, M; Colombo, C; Frapolli, R; Ferrari, R; Sitia, L; Dragoni, L; Bello, E; Licandro, Sa; Falcetta, F; Ubezio, P; Bigini, P; Salmona, M; D'Incalci, M; Morbidelli, M; Moscatelli, D | |
| CHANGES IN THE SYNTHESIS OF HISTONE H1-DEGREES AND H-1 IN RAT FRTL-5 THYROID-CELLS EXPOSED TO THYROTROPIN | 1-gen-1989 | Mannironi, C; Erba, E; Corda, D; Gianellini, L; D'Incalci, M | |
| The novel lipophilic camptothecin analogue gimatecan is very active in vitro in human neuroblastoma: A comparative study with SN38 and topotecan | 1-gen-2005 | Di Francesco, Am; Riccardi, As; Barone, G; Rutella, S; Meco, D; Frapolli, R; Zucchetti, M; D'Incalci, M; Pisano, C; Carminati, P; Riccardi, R | |
| IFN-beta partially counteracts inhibition of natural killer activity induced by some antitumor agents | 1-gen-1998 | Allavena, P; Giardina, G; Sen, S; Colella, G; Broggini, M; D'Incalci, M | |
| Novel Models of Myxoid Liposarcoma Xenografts Mimicking the Biological and Pharmacologic Features of Human Tumors | 1-gen-2010 | Frapolli, R; Tamborini, E; Virdis, E; Bello, E; Tarantino, E; Marchini, S; Grosso, F; Sanfilippo, R; Gronchi, A; Tercero, Jc; Peloso, G; Casali, P; Pilotti, S; D'Incalci, M | |
| Idarubicin and melphalan as myeloablative regimen after sequential high dose chemotherapy for lymphomas: Preliminary results of a phase I-II study with pharmacokinetical guided peripheral blood progenitor cell reinfusion | 1-gen-1997 | Peccatori, F; Cocorocchio, E; Munzone, E; Corsini, C; Zucchetti, M; Ferrucci, Pf; Cinieri, S; D'Incalci, M; Martinelli, G | |
| Phase II trial of salvage therapy with trabectedin in metastatic pancreatic adenocarcinoma | 1-gen-2016 | Belli, C; Piemonti, L; D'Incalci, M; Zucchetti, M; Porcu, L; Cappio, S; Doglioni, C; Allavena, P; Ceraulo, D; Maggiora, P; Dugnani, E; Cangi, Mg; Garassini, G; Reni, M | |
| Paclitaxel induces significant changes in epidoxorubicin distribution in mice | 1-gen-1996 | Colombo, T; Paz, Og; Zucchetti, M; Maneo, M; Sessa, C; Goldhirsch, A; D'Incalci, M | |
| Development of distamycin-related DNA binding anticancer drugs | 1-gen-2001 | Marchini, S; Broggini, M; Sessa, C; D'Incalci, M | |
| Increased sensitivity to platinum drugs of cancer cells with acquired resistance to trabectedin | 1-gen-2015 | Colmegna, B; Uboldi, S; Frapolli, R; Licandro, Sa; Panini, N; Galmarini, Cm; Badri, N; Spanswick, Vj; Bingham, Jp; Kiakos, K; Erba, E; Hartley, Ja; D'Incalci, M | |
| Effects of a novel DNA-damaging agent on the budding yeast Saccharomyces cerevisiae cell cycle | 1-gen-1996 | Popolo, L; Vigano, F; Erba, E; Mongelli, N; D'Incalci, M | |
| Use of cancer chemopreventive phytochemicals as antineoplastic agents | 1-gen-2005 | D'Incalci, M; Steward, Wp; Gescher, Aj | |
| alpha 1 acid glycoprotein binds to imatinib (ST1571) and substantially alters its pharmacokinetics in chronic myeloid leukemia patients | 1-gen-2003 | Gambacorti-Passerini, C; Zucchetti, M; Russo, D; Frapolli, R; Verga, M; Bungaro, S; Tornaghi, L; Rossi, F; Pioltelli, P; Pogliani, E; Alberti, D; Corneo, G; D'Incalci, M | |
| microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial-mesenchymal transition | 1-gen-2014 | Parikh, A; Lee, C; Joseph, P; Marchini, S; Baccarini, A; Kolev, V; Romualdi, C; Fruscio, R; Shah, H; Wang, F; Mullokandov, G; Fishman, D; D'Incalci, M; Rahaman, J; Kalir, T; Redline, Rw; Brown, Bd; Narla, G; Difeo, A |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista27918
Data di pubblicazione
- In corso di stampa14
- 2020 - 20269653
- 2010 - 201911835
- 2000 - 20094579
- 1990 - 19991485
- 1980 - 1989329
- 1975 - 197923
Editore
- Edition AERCV1
- Elsevier1
- Futura Publishing Company1
- Grafica Luigi Monti s.r.l.1
- Karger, Basel1
- Mosby1
- sn1
- Springer-Verlag1
- Thieme1
Rivista
- DIGESTIVE AND LIVER DISEASE372
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...267
- ANNALS OF ONCOLOGY244
- CANCERS232
- PLOS ONE223
- THE JOURNAL OF NUCLEAR MEDICINE222
- JOURNAL OF CLINICAL MEDICINE215
- EUROPEAN JOURNAL OF CANCER205
- GASTROINTESTINAL ENDOSCOPY197
- ALLERGY180
Keyword
- Humans2166
- Female1035
- Male996
- Middle Aged767
- Aged669
- Adult559
- COVID-19442
- Treatment Outcome373
- Animals329
- Retrospective Studies264
Lingua
- eng19972
- ita459
- spa14
- fre11
- ger8
- enm4
- por2
- chi1
Accesso al fulltext
- no fulltext25665
- reserved1362
- open891